DIAGNOS Inc.
DGNOF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $11 | $19 | $18 | $26 |
| % Growth | -43.9% | 5.5% | -29.4% | – |
| Cost of Goods Sold | $270 | $392 | $309 | $301 |
| Gross Profit | -$259 | -$372 | -$290 | -$275 |
| % Margin | -2,377.6% | -1,919.5% | -1,578.4% | -1,054.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $653 | $664 | $1,007 | $794 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$24 | -$3 | -$13 | $0 |
| Operating Expenses | $630 | $661 | $994 | $794 |
| Operating Income | -$726 | -$1,033 | -$1,285 | -$1,069 |
| % Margin | -6,670.5% | -5,326.3% | -6,984.8% | -4,103.6% |
| Other Income/Exp. Net | -$61 | -$80 | -$53 | -$145 |
| Pre-Tax Income | -$787 | -$1,113 | -$1,337 | -$1,213 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$787 | -$1,113 | -$1,337 | -$1,213 |
| % Margin | -7,232.4% | -5,738% | -7,270.7% | -4,658.8% |
| EPS | -0.008 | -0.011 | -0.014 | -0.014 |
| % Growth | 29.4% | 19.3% | 6.2% | – |
| EPS Diluted | -0.008 | -0.011 | -0.014 | -0.014 |
| Weighted Avg Shares Out | 102,258 | 101,863 | 98,980 | 77,982 |
| Weighted Avg Shares Out Dil | 102,258 | 101,863 | 98,979 | 77,981 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $17 | $0 | $0 |
| Interest Expense | $76 | $124 | $152 | $151 |
| Depreciation & Amortization | $24 | $34 | $31 | $33 |
| EBITDA | -$687 | -$956 | -$1,153 | -$1,029 |
| % Margin | -6,308.3% | -4,925.2% | -6,271.1% | -3,953.1% |